Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluBlok vs Fluzone in elderly adults
NCT00395174Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Oct 2006
- Primary completion
- May 2007
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Oct 2006; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00395174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395174.